- Home
- TNGX vs CRUS Comparison
TNGX vs CRUS Comparison
Compare TNGX & CRUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TNGX
- CRUS
- Stock Information
- Founded
- TNGX 2014
- CRUS 1984
- Country
- TNGX United States
- CRUS United States
- Employees
- TNGX N/A
- CRUS N/A
- Industry
- TNGX Biotechnology: Pharmaceutical Preparations
- CRUS Semiconductors
- Sector
- TNGX Health Care
- CRUS Technology
- Exchange
- TNGX Nasdaq
- CRUS Nasdaq
- Market Cap
- TNGX 351.2M
- CRUS 5.5B
- IPO Year
- TNGX N/A
- CRUS 1989
- Fundamental
- Price
- TNGX $6.01
- CRUS $104.87
- Analyst Decision
- TNGX Strong Buy
- CRUS Strong Buy
- Analyst Count
- TNGX 6
- CRUS 5
- Target Price
- TNGX $12.20
- CRUS $126.40
- AVG Volume (30 Days)
- TNGX 2.7M
- CRUS 515.4K
- Earning Date
- TNGX 08-06-2025
- CRUS 08-05-2025
- Dividend Yield
- TNGX N/A
- CRUS N/A
- EPS Growth
- TNGX N/A
- CRUS 22.45
- EPS
- TNGX N/A
- CRUS 6.00
- Revenue
- TNGX $40,990,000.00
- CRUS $1,896,077,000.00
- Revenue This Year
- TNGX N/A
- CRUS N/A
- Revenue Next Year
- TNGX N/A
- CRUS $7.88
- P/E Ratio
- TNGX N/A
- CRUS $17.36
- Revenue Growth
- TNGX 10.09
- CRUS 5.99
- 52 Week Low
- TNGX $1.03
- CRUS $75.83
- 52 Week High
- TNGX $12.02
- CRUS $147.46
- Technical
- Relative Strength Index (RSI)
- TNGX 76.36
- CRUS 49.03
- Support Level
- TNGX $5.34
- CRUS $102.33
- Resistance Level
- TNGX $6.40
- CRUS $111.48
- Average True Range (ATR)
- TNGX 0.50
- CRUS 2.83
- MACD
- TNGX -0.02
- CRUS -0.40
- Stochastic Oscillator
- TNGX 84.08
- CRUS 24.10
About TNGX Tango Therapeutics Inc.
Tango Therapeutics Inc is a biotechnology company. It is dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. It is currently developing two MTA-cooperative PRMT5 inhibitors; TNG462 for non-CNS cancers, including pancreatic and lung cancer, and TNG456, a next-generation, brain-penetrant PRMT5 inhibitor, for CNS cancers, including GBM. Its pipeline products are PRMT5 and CoREST.
About CRUS Cirrus Logic Inc.
Cirrus Logic Inc is a provider of integrated circuits for audio and voice signal processing applications. The firm's products are organized into two streams: portable audio products, and HPMS Products. These products include aAmplifiers, codecs, smart codecs, analog-to-digital converters, digital-to-analog converters and standalone digital signal processors, Camera controllers, haptics and sensing solutions, and battery and power ICs. Roughly half of the firm's revenue is generated in China, with the rest coming from the United States, Europe, South Korea, and countries across the world.